These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6104842)

  • 1. Hypothermic effects of N-n-propylnorapomorphine in mice: antagonism by neurotransmitter receptor blockers.
    Wilcox RE; Riffee WH; Smith RV
    Psychopharmacology (Berl); 1980; 68(1):85-8. PubMed ID: 6104842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia.
    Moore NA; Axton MS
    Eur J Pharmacol; 1990 Mar; 178(2):195-201. PubMed ID: 2184043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice.
    Riffee WH; Wilcox RE; Smith RV
    Eur J Pharmacol; 1979 Mar; 54(3):273-7. PubMed ID: 570924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats.
    Wade RL; Quock RM; Malone MH
    J Pharm Pharmacol; 1984 Oct; 36(10):673-6. PubMed ID: 6150084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothermic effects of apomorphine homologues in mice.
    Menon MK; Clark WG; Cannon JG
    J Pharm Pharmacol; 1979 May; 31(5):318-21. PubMed ID: 37302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of behavioral arousal induced by apomorphine and N-n-propylnorapomorphine.
    Riffee WH; Wilcox RE; Smith RV
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):301-12. PubMed ID: 569888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
    Menon MK; Clark WG; Neumeyer JL
    Eur J Pharmacol; 1978 Nov; 52(1):1-9. PubMed ID: 569056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors.
    Meller E; Hizami R; Kreuter L
    Pharmacol Biochem Behav; 1989 Jan; 32(1):141-5. PubMed ID: 2567521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sauvagine-induced hypothermia: evidence for an interaction with the dopaminergic system.
    Broccardo M; Improta G
    Eur J Pharmacol; 1994 Jun; 258(3):179-84. PubMed ID: 7916301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological basis for N-n-propylnorapomorphine induced stereotypic cage climbing and behavioral arousal in mice.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Dec; 11(6):653-9. PubMed ID: 43980
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.
    Sperk G; Campbell A; Baldessarini RJ; Stoll A; Neumeyer JL
    Neuropharmacology; 1982 Dec; 21(12):1311-6. PubMed ID: 6891445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B; Naylor RJ; Neumeyer JL
    Eur J Pharmacol; 1975 Mar; 31(1):1-16. PubMed ID: 1168579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor mediated hypothermic action of B-HT 920 in rats.
    Verma A; Kulkarni SK
    J Pharm Pharmacol; 1991 Jun; 43(6):421-4. PubMed ID: 1681056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
    Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.
    Wilcox RE; Riffee WH; Chen PC; Hammett S; Smith RV
    Psychopharmacology (Berl); 1980; 72(1):113-5. PubMed ID: 6781003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
    Campbell A; Baldessarini RJ; Neumeyer JL
    Psychopharmacology (Berl); 1993; 111(3):351-8. PubMed ID: 7870974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B; Naylor RJ
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.
    Campbell A; Baldessarini RJ; Ram VJ; Neumeyer JL
    Neuropharmacology; 1982 Oct; 21(10):953-61. PubMed ID: 6890636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.